Story Timeline
Who reported a story first, and how coverage spread across the spectrum.
Remdesivir in Immunocompromised Patients: Survival Benefit?
1 articles over 1 hours.
First centreMedscapefirst overall
- MedscapeCenterRemdesivir in Immunocompromised Patients: Survival Benefit?
How this was worked out
Every article INDB grouped into this story, in the order the outlets published them (times in UTC, from the outlets' feeds).
How INDB scores stories · Data: stories INDB grouped from the outlets on the sources page.